Trial
NCT04447235
Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Instituto do Cancer do Estado de São Paulo
Collaborators
—
Condition
Cancer
Intervention
Placebo
Why stopped
futility analysis has demonstrated no difference between arms
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-09